clinical trial · NCT00650403
Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
HealthyParoxetine hydrochloride 40 mg tabletPaxil® 40 mg Tablet
brief summary
The objective of this study is to investigate the bioequivalence of Mylan's paroxetine hydrochloride 40 mg tablets to GSK's Paxil® 40 mg tablets following a single, oral 40 mg (1 x 40 mg) dose administered under fed conditions to healthy adult volunteers.
started
Dec 1, 2006
primary completion
Dec 1, 2006
completion
Jan 1, 2007
last updated
Apr 24, 2024
official title
Single-Dose Fed Bioequivalence Study of Paroxetine Hydrochloride Tablets (40 mg; Mylan) and Paxil® Tablets (40 mg; GSK) in Healthy Adult Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol